5-alfa-reductase inhibitor

Alpha Blockers Linked to Prostate Cancer Relapse

A retrospective study has just been published that shows that the risk of experiencing a biochemical recurrence (PSA recurrence) after radical prostatectomy to treat prostate cancer increased significantly in men who received alpha blockers for lower urinary tract symptoms (LUTS) after surgery. When compared to men who did not receive alpha blockers, those who did [...]

By Malecare|2017-10-19T10:51:57-04:00October 26th, 2011|Advanced Prostate Cancer, Drugs & Treatments, General Information, Uncategorized, Understanding APC|0 Comments

FDA: 5-Alpha-Reductase Inhibitors May Increase High-Grade Prostate Cancer Risk

There is a constant debate between both oncologist and advocates about the value and safety of 5-alpha-reductase inhibitors (Proscar and Avodart) both in the early treatment and later treatment of men with prostate cancer. In fact, I have had an on-going private debate with one very knowledgeable educator advocate over this issue. I often have [...]

By Malecare|2017-10-19T10:52:24-04:00June 23rd, 2011|Advanced Prostate Cancer, Drugs & Treatments, FDA, General Information, Politics of Cancer, Res